Year All20252024202320222021202020192018201720162015201420122011 Dec 1, 2014 Ardelyx Appoints Jeremy S. Caldwell, Ph.D., as Executive Vice President and Chief Scientific Officer Nov 17, 2014 Ardelyx's Tenapanor Reduces Phosphorus Absorption and Protects against Vascular Calcification in Preclinical In Vivo Model of Chronic Kidney Disease Nov 6, 2014 Ardelyx Reports Third Quarter 2014 Financial Results Oct 30, 2014 Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 Oct 23, 2014 Ardelyx's Tenapanor Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2014 Oct 1, 2014 Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients Sep 5, 2014 Ardelyx Chief Scientific Officer, Dominique Charmot, Announces Retirement from the Company at Year-End Aug 7, 2014 Ardelyx Reports Second Quarter 2014 Financial Results Aug 5, 2014 Ardelyx to Present at the Wedbush 2014 Life Sciences Management Access Conference Jun 24, 2014 Ardelyx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares